文献速递白血病

CBFA2T3-GLIS2阳性急性髓系白血病:一种独特的儿科实体

CBFA2T3-GLIS2-positive acute myeloid leukaemia. A peculiar paediatric entity.
PubMed 文献 · Br J Haematol · 2018-12-28

本文综述CBFA2T3-GLIS2阳性急性髓系白血病的临床与生物学特征。该融合基因由16号染色体隐匿性倒位产生,是儿童非唐氏综合征急性巨核细胞白血病中最常见的嵌合癌基因,尚未在成人中发现。该融合与极差预后相关,各病例系列报告的总生存率介于15%至30%之间。

要点

  • CBFA2T3-GLIS2由16号染色体隐匿性倒位形成,是儿童非唐氏综合征急性巨核细胞白血病中最常见的嵌合癌基因。
  • 该融合基因定义了一种儿科特有的白血病亚型,尚未在成人中检出。
  • 携带该融合的病例系列报告总生存率介于15%至30%之间,预后极差。

核心结论

  • CBFA2T3-GLIS2阳性急性髓系白血病是儿科特有的侵袭性亚型,几乎在所有已报告病例系列中均与不良结局相关,总生存率介于15%至30%之间。

研究设计与样本

  • 本文为综述,基于大规模基因组测序技术进展,总结CBFA2T3-GLIS2阳性急性髓系白血病的临床与生物学特征及潜在靶向治疗机会。

主要发现

  • CBFA2T3-GLIS2融合基因由16号染色体隐匿性倒位产生,是迄今在非唐氏综合征急性巨核细胞白血病中识别出的最常见嵌合癌基因。
  • 该融合基因似乎并非仅局限于法国-美国-英国M7亚组。
  • 该融合基因定义了一种儿科特有的白血病亚型,从未在成人中识别出。
  • 携带该融合基因的病例系列报告总生存率介于15%至30%之间。
  • 尽管该亚型的分子基础远未完全阐明,近期已识别出CBFA2T3-GLIS2在白血病发生驱动过程中诱导的独特功能特性。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The scenario of paediatric acute myeloid leukaemia (AML), particularly non-Down syndrome acute megakaryoblastic leukaemia (non-DS-AMKL), has been recently revolutionized by the advent of large-scale, genomic sequencing technologies. In this changing landscape, a significantly relevant discovery has been represented by the identification of the CBFA2T3-GLIS2 fusion gene, which is the result of a cryptic inversion of chromosome 16. It is the most frequent chimeric oncogene identified to date in non-DS-AMKL, although it seems not to be exclusively restricted to the French-American-British M7 subgroup. The CBFA2T3-GLIS2 fusion gene characterizes a subtype of leukaemia that is specific to paediatrics, having never been identified in adults. It characterizes an extremely aggressive leukaemia, as the presence of this fusion is associated with a grim outcome in almost all of the case series reported, with overall survival rates ranging between 15% and 30%. Although the molecular basis that underlies this leukaemia subtype is still far from being completely elucidated, unique functional properties induced by CBFA2T3-GLIS2 in the leukaemogenesis driving process have been recently identified. We here review the peculiarities of CBFA2T3-GLIS2-positive AML, describing its intriguing clinical and biological behaviour and providing some challenging targeting opportunities.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Masetti R, Bertuccio SN, Pession A, et al. CBFA2T3-GLIS2-positive acute myeloid leukaemia. A peculiar paediatric entity. Br J Haematol. 2018. PMID: 30592296. doi:10.1111/bjh.15725

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。